BioMerieux (BIMp)
Euronext Paris • Healthcare
February 27, 2026 at 16:30 UTC
Name
CEO
Website
Industry
Year Founded
Employees
BioMerieux is an in vitro diagnostics company that designs systems, reagents, and software used in clinical laboratories and public-health settings. The portfolio supports microbiology, immunoassay, and molecular workflows, and products are developed to fit validation and quality routines in regulated environments. Manufacturing and field support operate under a single quality framework, and documentation is written for accreditation bodies as well as lab managers. Country organizations handle market access and training while core engineering and medical information remain centralized. The company’s stance in the healthcare ecosystem is method first: evidence, labeling, and service are kept in step so laboratories can adopt platforms without rewriting daily practice. Activity spans many regions with logistics tuned to cold-chain and service windows.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
BioMerieux's Technical Indicators Summary
BIMp is exhibiting a broadly bearish profile as it trades slightly above the VWAP but below most key moving averages, including the 200-day EMA, which suggests downward pressure remains intact. Momentum indicators such as the MACD and CCI confirm weakening momentum, while the RSI hovers near oversold territory without signaling a strong reversal. The ADX indicates a moderately strong trend, leaning bearish, and volume trends on the OBV support selling pressure. Despite a low Stochastic and Williams %R hinting at potential short-term relief, overall technical conditions favor continued caution, with resistance near the classic pivot around 103.70. The technical takeaway is that BIMp remains under sustained selling influence amid persistent downward momentum.
| Indicator | Value |
|---|---|
RSI (14) | 31.66 |
Stochastic %K (14, 3, 3) | 10.15 |
CCI (20) | -179.32 |
WPR (14) | -94.20 |
Momentum (10) | -11.70 |
MFI | 28.84 |
MACD Level (12, 26) | -0.94 |
Bollinger Bands | $103.17 - $115.82 |
ATR (14) | $2.16 (2.10%) |
ADX (14) | 25.64 |
OBV | 682,975 |
VWAP | $103.07 |
Classic Pivot Point | $103.70 |
Fibonacci Pivot Point | $103.70 |
Simple Moving Averages | $108.05 - $115.28(5 indicators) |
Exponential Moving Averages | $107.03 - $113.34(5 indicators) |
Get premium market insights delivered directly to your inbox.
With the print approaching on 2026-02-27 in roughly 0 days, BIMp is setting up at 101.30. The broader group is inching higher (0.97%), offering a light supportive breeze. BIMp edges higher as the sector peers rise, providing a light, supportive breeze ahead of the print.
Price Change
from €96.4 close
+€4.9
Trading Volume
Below avg (125.9K)
63.4K
vs S&P 500 Today
Strong Outperformance
+5.43%
52-Week Position
Lower range
25.9%
Updated: February 27, 2026 at 16:42 UTC